Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06505863
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-11
Brief Title:
Quality of Life After Transanal Total Mesorectal Excision Compared to Traditional Total Mesorectal Excision
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Does Transanal Total Mesorectal Excision taTME Result in Better Quality of Life and Functional Outcomes Than Traditional Total Mesorectal Excision A Retrospective Propensity Score-adjusted Cohort Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The improvement in prognosis of rectal cancer through modern therapy modalities rises questions regarding quality of life QoL and functional outcomes Evidence for long-term QoL and functional outcomes of transanal total mesorectal excision taTME is not provided in current literature This study will compare short-term and long-term QoL and functional outcomes after taTME compared to traditional abdominal TME laparoscopic robotic and open approach
Detailed Description:
Quality of life and functional outcomes of patients undergoing taTME or abTME for stage I-III rectal cancer will be analysed A retrospective propensity score-adjusted analysis of prospectively conducted data will be performed The primary endpoint QoL will be assessed by the European Organization for Research and Treatment of Cancer core questionnaire EORTC QLQ-C30 Secondary endpoints are the functional outcomes according to the EORTC QLQ-C30 questionnaire
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None